The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Gje306...' much better to let the nomad leak the info to the city,'....and make sure TW gets a wiff too...
Ah...how money begets money...
So what happened to wyndrums post in this where they suggested I was just trying to trip them up rather than having a discussion about the SP? How was this selectively removed and why tf was it removed?
PL75....'Suspect they're all at it. Sitting about waiting for AIM companies to give them the chance to make a few bob at PIs expense'...
Errrrr! I can't believe you've only just realised that's why II's love fundraisers so much...for this very reason that's why I was , and still am, hoping that the European Speciality Fund is the likes of Medicxi because they would be in for the long haul.
Did someone say there was a 40 day rule which ends on 9 April?
So let's see what that brings in the way of news or is it just a postr of what we've already been told.
DTW...' the majority of fund managers do not have an understanding of the science at AVCT.'...they know very little about most of the companies they are invested in. Unfortunately well researched PI's tend to think II's must be the same or that they may know more. In my experience this s not the case unless they've gone Inside and even the information the might get then is put out to the wider market in a matter of days/weeks at the most.
I'd even bet some of the information put out by Avacta's partners doesn't even hit the desks in Avacta. We've had several postings on here which would have made nice news items for Avacta and we've seen nothing. They can't blame an NDA because the information was made public knowledge by the said company.
Played. Why not lean on PI's for the funds? Probably advised by the nomad that they themselves would leak the information resulting in a price crash and ultimately risk failing to raise at all. No, much better to let the nomad leak the info to the city, cause a price crash, and then do a 50% discount placing with their city mates.
Brilliant - so the discount to the latest price swung things for a fund that's clearly going to flog them given the chance. Nice one Alan, you've really improved the shareholder register there. Also, a shame the ratty scum had already hacked it down to result in a nice round 50p as a discount from 120p would have been better.
Suspect they're all at it. Sitting about waiting for AIM companies to give them the chance to make a few bob at PIs expense. Tis what it is....
This is the one I was referring to: https://www.voxmarkets.co.uk/articles/vox-markets-fund-manager-series-oliver-brown-of-rc-brown-6fb431a/
Gje306 - you only have to listen to that recent interview with Gervais at Premier Milton to realise that the majority of fund managers do not have an understanding of the science at AVCT.
He is a long term holder of AVCT shares and his understanding was rudimentary.
It wasn't premier Milton PL75, can't remember who it was. But he said they bought because it was cheap.
Missed that one gje, was that Premier Miton by any chance? He's previously said that he actively trades his AVCT holding so of course they'd buy shares at a ridiculous mates rates discount.
"AS has a lot of explaining to do. Will he be forthcoming and honest though? That's the question."
No, he's raised 30 million, in his eyes we should all be happy (and forget that most long term holders have averages above a quid).
You assertions were all over the place Wyndrum, that is all. You lean on "the market" to back up your arguments, but they are on the whole none the wiser. Do they know or don't they know? Paul Hill's interview with the fund manager who participated in the fund raise would that suggest they don't know. He freely admitted they don't have any specialists that can interpret the results to date and it was simply the fund raise at 50p that made the offer attractive, and "pushed the risk reward in their favour". He also let slip that this was popular with retail. Adding the two together, you could probably surmise that in this case the fund manager was none the wiser and just took the judgement that this stock is a retail favourite and the share would be trading back up at 90p soon enough.
Just to make the point abundantly clear, this was not some insightful play by this fund manager where they reflected on either the underlying science nor the trial progress to date, they looked at it as purely a trade play. In which case your statement:
"The market, who actually do have the technical ability to lift the bonnet, is not yet convinced."
in this case clearly does not apply. If this was the prevailing attitude or analysis that took place in the city, then you could say that the price only dropped down to 50p because they all saw a trading opportunity, especially when "the market" caught wind of the raise.
Why were there not other city funds willing to cough up at 100p for the placing, you might ask. All for the same reason as above, they just want to de-risk relative to the average retail appetite for this stock. I wouldn't read anything further into it in terms of it being a reflection of whether the tech works or not.
AS has a lot of explaining to do. Will he be forthcoming and honest though? That's the question.
Sod AS but the independent clinicians would not be recommending their patients continue to go into hospital to take AVA6000 if they did not believe it was helping. The fact that dox can stabilise or get rid of tumours over a period of less than 5 months and we are able to dose over double that (dose dependent) and these patients won't have the awful side effects it's exciting. Depending on what comes out of the wash over the next month AS and the CFO may have to go and I'm sure they'll need some positive to get the share price a lot higher and some solid reasons why the 50p raise to stop some shareholders forcing an EGM
Who’s the market wyndrum? That’s you and me. In one breath you say:
“All we know for sure is that the wrapper works.”
And then contradict yourself with:
“The market, who actually do have the technical ability to lift the bonnet, is not yet convinced.”
You seem confused as to extent of what we do know and what can be known.
You really think a major Euro fund isn't going to do due diligence before investing millions in Avacta.
"The technology however is performing tremendously."
is it? Who says? Please don't say its based on what AS says.
Thats the problem. If we discredit AS 's outpourings then what does that mean for how good the tech really is?
All we know for sure is that the wrapper works. What happens after that is not yet clear.
The market, who actually do have the technical ability to lift the bonnet, is not yet convinced. At this stage I'll take my lead from them.
(And as for Paul Hill, it was obviously staged, scripted interviews driven by AS. )
Seems the overall message is coming through loud and clear here now - excellent technology, highly promising company - if only the would unload their shambolic liability of a CEO.
Any chance we could be next?
Exactly right. He’s chosen time and again to consult his 36 month calendar and still be late.
The technology however is performing tremendously. Look past AS and the investment becomes less lost. Somebody, at some point will buy it and AS won’t be able to do anything about it.
No one should give any weight to what AS says.
The clinicians however present a consistently positive story.
Great start to the morning....'TheValueCurve' troll consigned to the bin 22 negative posts!
Spot the pattern…..
Affimer platform ramped to heaven by AS - still not a regulatory filing on a single asset, 15 years after it was invented.
LFT - huge interest, 200 million tests a month. Abject failure.
Precision - Going to change how cancer is treated, but it’s only us telling you that as BP aren’t interested.
It’s all the same nonsense from a rampy ex-scientist CEO who saw an opportunity to boost his pay 10x.
He’s completely untrusted now.
I don't think anything about TheValueCurve. She just throws out unqualified, simplistic statements. No one should fall for such rubbish: if someone makes a contrary statement without any reasoning or argument, that statement should be ignored. Anyone can make anything up. Doesn't mean it should be entertained, even if TheValueCurve did go with five men last night.🥴